Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Carcinoma, Small Cell
×
Etoposide
×
Clear all
Filters
3
NCT03699956
2024-03-26
REPLATINUM
EpicentRx, Inc.
Phase 3
Terminated
18 enrolled
NCT00826644
2021-08-09
COMBAT
Chonnam National University Hospital
Phase 3
Completed
147 enrolled